Pleasanton, CA, United States of America

Tetsuya Kobayashi

This inventor holds 33 USPTO granted patents and 15 published patent applications, plus 1 CIPO patent and 15 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Gilead Sciences, Inc., Gilead Pharmasset LLC, Carna Biosciences, Inc.. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tetsuya Kobayashi. Retrieved from https://idiyas.com/inventor/tetsuya-kobayashi-dqcvk02k

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 33 (Patent Applications = 15)

% Patents Active = 97.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 15 (Patent Applications = 19)

Average Co-Inventor Count = 11.2

ph-index = 7

Forward Citations = 156(Granted Patents)

Location History:

Sunnyvale, CA (US) (2010 - 2016)
Foster City, CA (US) (2023)
Pleasanton, CA (US) (2016 - 2024)

Company Filing History:

30 out of 946

Gilead Sciences, Inc.

patents

2 out of 81

Gilead Pharmasset LLC

patents

1 out of 13

Carna Biosciences, Inc.

patents

4. 1 out of 15

Gilead Palo Alto, Inc.

patents

5. 1 out of 10

The Endowment for Research in Human Biology, Inc.

patents

where one patent can have more than one assignee

Years Active: 2010-2025

Loading Chart...

Areas of Expertise:

MCL1 Inhibitors

Substituted Pyrrolizine Compounds

Diacylglycerol Kinase

Benzimidazole Derivatives

Hepatitis C Virus

Fused Heterocyclic Compounds

Ion Channel Modulators

ALDH-2 Inhibitors

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12202842 - MCL1 inhibitors (2025-01-21),

2. 12162844 - MCL-1 inhibitors (2024-12-10),

3. 12161625 - Substituted pyrrolizine compounds and uses thereof (2024-12-10),

4. 12054490 - Diacylglycerol kinase modulating compounds (2024-08-06),

5. 11976072 - Diacylglycerol kinase modulating compounds (2024-05-07),

6. 11932634 - Diacylglycerol kinase modulating compounds (2024-03-19),

7. 11926628 - Diacylglyercol kinase modulating compounds (2024-03-12),

8. 11845723 - Diacylglycerol kinase modulating compounds (2023-12-19),

9. 11667652 - MCL1 inhibitors (2023-06-06),

10. 11643400 - MCL-1 inhibitors (2023-05-09),

11. 11420974 - Substituted pyrrolizine compounds and uses thereof (2022-08-23),

12. 10988451 - MCL-1 inhibitors (2021-04-27),

13. 10874640 - Substituted pyrrolizine compounds and uses thereof (2020-12-29),

14. 10836769 - Substituted pyrrolizine compounds and uses thereof (2020-11-17),

15. 10703733 - MCL-1 inhibitors (2020-07-07),

Title: The Innovative Journey of Tetsuya Kobayashi

Introduction: Tetsuya Kobayashi, a visionary inventor based in Pleasanton, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Tetsuya Kobayashi holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a background in engineering and a passion for problem-solving, Tetsuya Kobayashi has led successful projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Tetsuya Kobayashi has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and create tangible solutions for complex challenges.

Conclusion: Tetsuya Kobayashi's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.